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²Dana Farber Cancer Institute and the Department extensively reviewed (Tonks, 1996; Neel and Tonks,
1997). SHP-2 is expressed in every tissue and transmitsof Biological Chemistry and Molecular Pharmacology
Harvard Medical School signals in cells that are activated by various ligands,
including growth factors, cytokines, hormones, andBoston, Massachusetts 02115
MHC-antigen complexes. SHP-1 expression is limited
primarily to hematopoietic and epithelial cells. SHP-2
(or Csw) is critical for normal development in XenopusSummary
laevis (Tang et al., 1995; O'Reilly and Neel, 1998) and
Drosophila (Perkins et al., 1992; Allard et al., 1996); miceThe structure of the SHP-2 tyrosine phosphatase, de-
that are homozygous for mutant or null SHP-2 allelestermined at 2.0 AÊ resolution, shows how its catalytic
die in utero (Arrandale et al., 1996; Saxton et al., 1997).activity is regulated by its two SH2 domains. In the
In addition to binding activated receptors, SHP-2 bindsabsence of a tyrosine-phosphorylated binding partner,
receptor substrates like IRS-1 (Kuhne et al., 1993) andthe N-terminal SH2 domain binds the phosphatase do-
several recently identified adhesion molecules, includ-main and directly blocks its active site. This interaction
ingmembrane-spanning SHPS/SIRP and PECAM proteinsalters the structure of the N-SH2 domain, disrupting its
(Fujioka et al., 1996; Jackson et al., 1997; Kharitonenkovphosphopeptide-binding cleft. Conversely, interaction
et al., 1997). To understand how the phosphatase activ-of the N-SH2 domain with phosphopeptide disrupts
ity of SHP-2 is regulated by interaction of its SH2 do-its phosphatase recognition surface. Thus, the N-SH2
mains with these phosphoproteins, we have determineddomain is a conformational switch; it either binds and
the structure of SHP-2.inhibits the phosphatase, or it binds phosphoproteins
and activates the enzyme. Recognition of bisphos-
Results and Discussionphorylated ligands by the tandem SH2 domains is an
integral element of this switch; the C-terminal SH2
The crystallized protein (residues 1±527) comprises thedomain contributes binding energy and specificity, but
two SH2 domains and the entire catalytic PTP domainit does not have a direct role in activation.
of human SHP-2 but lacks the 66-residue C-terminal
tail. The truncated protein is activated by phosphopep-Introduction
tides like the full-length enzyme (data not shown). The
structure has been refined to a crystallographic R valueMany cytoplasmic signaling enzymes are both targeted
of 20%, using data to2.0 AÊ resolution. Structure determi-and regulated by interactions of their SH2 domains with
nation and refinement statistics are presented in Tablephosphotyrosine docking sites created by receptor acti-
1. A portion of the electron density map and refinedvation (for reviews, Cohen et al., 1995; Pawson, 1995;
atomic model are shown in Figure 1A.Kuriyan and Cowburn, 1997). The SH2 domain phospha-
tases (SHP-1, SHP-2, and csw, a Drosophila melano-
gaster homolog) provide prime examples of this effect. Domain Organization and Structure
These proteins share a common architecture compris- The crystal structure reveals a ªclosedº domain arrange-
ing two SH2 domains followed by a tyrosine phospha- ment in which the two SH2 domains contour around
tase (PTP) domain, and a C-terminal extension. SHPs are the phosphatase domain (Figures 2A and 2B). The
essentially inactive under basal conditions, but catalytic N-terminal SH2 domain binds intramolecularly to the
activity (kcat) increases dramatically in parallel with SH2 PTP domain; it interacts extensively with the catalytic
domain occupancy (Lechleider et al., 1993; Sugimoto et domain and directly blocks the phosphatase active site.
al., 1993; Townley et al., 1993; Dechert et al., 1994; Pei The C-terminal SH2 domain is tethered to the adjacent
et al., 1994, 1996; Pluskey et al., 1995; Eck et al., 1996). domains by peptide backbone but does not share a
Single phosphopeptides that bind oneSH2 domain stim- significant interface with either the N-terminal SH2 do-
ulate PTP activity about 10-fold. Relevant bisphosphoryl main or the PTP domain. The phosphopeptide binding
sequences that bind both SH2 domains stimulate cataly- sites of both SH2 domains face away from the phospha-
sis up to 100-fold and at much lower peptide concentra- tase domain and are fully exposed on the surface of
tions. Several other signaling enzymes are regulated by the molecule. A distinct, nonoverlapping surface of the
their SH2 domains, including PI 3-kinase, PLC-g1, and N-terminal domain creates the specific interface with
the PTP domain. Although the domains are compactly
organized, they appear to interact only loosely. The ma-³To whom correspondence should be addressed.
§These authors contributed equally. jority of interdomain contacts are polar, and numerous
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Table 1. Data Collection, Structure Determination, and Refinement Statistics
Data Collection
Space group P21
Unit cell a 5 45.63 AÊ , b 5 213.02 AÊ , c 5 55.41 AÊ
a 5 g 5 908, b 5 96.38
Reflections (observed/unique) 276,084/71,634
Rmerge 6.17% (29.6% in outer 2.1-2.0 AÊ shell)
Completeness 93.9% (82.5% in outer 2.1±2.0 AÊ shell)
Refinement
Resolution 8.0±2.0 AÊ
Rcryst/Rfree (I . 1s) 22.8/29.0
Number of reflections used 62,840
Rcryst/Rfree (I . 2s) 19.9/27.0
Number of reflections used 47,820
RMS deviation (bonds/angles) 0.009 AÊ /1.58
B value (average/bonded SD) 28.0 AÊ 2/1.76 AÊ 2
water molecules bind in the interfaces between all do- are reduced. As in the tandem-SH2 structure, the phos-
phopeptide binding sites in SHP-2 are widely separatedmains. The polar nature of the intersubunit contacts
is consistent with the notion that these interfaces will (over 50 AÊ between the phosphotyrosine pockets), but
they are roughly perpendicular to one another (Figurebecome fully solvent exposed in the active form of the
enzyme. 2B). The divergence in SH2 domain orientations demon-
strates that in the activated form, the domains are likelyThe PTP domain of SHP-2 has a mixed a/b architec-
ture (Figures 2A and 3) that closely resembles the cata- to be flexible, rather than rigidly fixed with respect to
one another, as we previously suggested (Eck et al.,lytic domains of PTP1B, Yersinia PTP, PTPa, and PTPm
(Barford et al., 1994; Stuckey et al., 1994; Bilwes et al., 1996).
1996; Hoffmann et al., 1997); 203 core a carbons of the
SHP-2 and PTPa catalytic domains superimpose with The Mechanism of Inhibition
The structure reveals a clear mechanism for catalytican rmsd of 0.66 AÊ . The PTP domain of SHP-2 contains
nine a helices and 14 b strands. Ten of the b strands inhibition; the N-terminal SH2 domain directly blocks
the enzyme active site (Figures 1, 2 and 4). The N-SH2form a mixed parallel/antiparallel b sheet that wraps
around helix aE. Helices A, B, F, G, H, I, and J pack and the PTP share a broad interaction surface of approx-
imately 1208 AÊ 2 at each surface (Figure 5). The D9E looptogether on the opposite side of the large b sheet. Cata-
lytic mechanisms for PTPs are well established. Resi- and flanking D9 and E strands of the N-SH2 domain are
central to this interaction, and they extend deep intodues of the PTP signature motif, [I/V]HCxAGxxR[S/T]G
(single letter code; x 5 any amino acid), are found in the catalytic cleft. Key conserved features of the PTP
catalytic cleft include Cys459, the catalytic nucleophile;bM and aG and the MG loop between them. Strand bM
is at the center of the ten-strandedb sheet. The essential Arg465 and the ªphosphate binding cradleº formed by
several mainchain amide groups in the signature motif,nucleophilic cysteine and all functional groups required
for phosphate binding are in the signature motif. These which together coordinate the phosphate oxygens of
the bound substrate; and the WPD loop, which closesand other residues form a catalytic cleft at the base of
the phosphotyrosine binding pocket that extends to a around the bound phosphotyrosyl substrate and con-
tributes Asp425, the general acid in catalysis (Barforddepth of up to 9 AÊ from the molecular surface.
The N- and C-terminal SH2 domains have the con- et al., 1994; Stuckey et al., 1994; Jia et al., 1995). In our
autoinhibited structure, all of these residues are occu-served SH2 fold, which consists of a central four-
stranded b sheet that is flanked at either surface by an pied by interaction with the N-SH2 domain (Figures 1B,
4, and 5). The active site moieties that are expected toa helix. Phosphopeptides bind to SH2 domains in an
extended conformation, with the phosphotyrosine in a hydrogen bond to phosphate oxygens interact instead
with theN-SH2 domain or with one of three tightly boundpocket on one side of the central sheet and C-terminal
residues within a pocket or groove created by the EF water molecules that are coordinated between the SH2
and the PTP active site (Figures 1A and 1B). Side chainsand BG loops on the opposite side of the central sheet.
The phosphopeptide recognition sites of both SH2 do- of SH2 domain Asp61 and PTP domain Cys459 are hy-
drogen bonded through one of these water molecules.mains are empty, because no ligands were included in
the crystallization. An intricate intra- and interdomain hydrogen bonding
network, which involves Gly60, Asn58, Gln506, Ala72,The relative orientation of the two SH2 domains ob-
served here is different from that in our previous struc- and Gly503, stabilizes the D9E loop in the enzyme active
site (Figure 1B).ture of a ªtandem-SH2º domain fragment of SHP-2 (Eck
et al., 1996). In the tandem-SH2 structure, a disulfide Substrate binding causes a conformational reorgani-
zation of the WPD loop in PTP active sites (Stuckey etbond and a small hydrophobic interface between the
domains stabilizes an antiparallel orientation of the two al., 1994; Jia et al., 1995). In PTP1B, a backbone motion
of greater than 5 AÊ brings Asp181 (the general acid) andphosphopeptide binding sites, which are about 40 AÊ
apart. In the current structure, there is only a minimal Phe182 into the catalytic active site to participate in
catalysis and substrate binding (Figure 4). In SHP-2,polar interface between the domains, and the cysteines
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Figure 1. Stereo Figures in the Region of the SHP-2 Active Site
Residues of the phosphatase and N-SH2 domain are oriented similarly and colored green and yellow, respectively, in (A) and (B). Red, oxygen
atoms; blue, nitrogens; red spheres, ordered water molecules.
(A) The 2Fo-Fc electron density map and refined atomic model at the interface of the N-SH2 domain and PTP active site. The map is contoured
at 1.3 s and was calculated using data between 8.0 and 2.0 AÊ resolution.
(B) Numerous hydrogen bonds (thin white lines) stabilize the interface between the N-SH2 domain and PTP active site.
even though the D9E loop of the SH2 domain occupies (Figure 5). The complementary surface on the PTP do-
main is formed by residues of aB and aC and the DBthe substrate binding site and mimics some features of
phosphotyrosine binding, it does not induce closure of and aHI loops. Specific interactions include a salt bridge
between the side chains of Arg4 and Glu258 and hydro-the WPD loop. In fact, the bulky D9E turn (Asn58, Thr59,
and Gly60) prevents closure of the WPD loop and main- gen bonds from Asn281 to Glu69, from Ser502 to Glu76,
and from Gln506 to Ala72. If the structure of substrate-tains the active site in the open, inactive conformation
seen in PTPs without bound substrate (Figure 4). The bound PTP1B (Jia et al., 1995) predicts the orientation
of substrate peptide binding by SHP-2, then the SH2receptor-like phosphatase PTPa appears to be regu-
lated by a related steric block of its active site (Bilwes domain in our structure binds where substrate residues
C-terminal to phosphotyrosine would otherwise bind.et al., 1996). The proximal PTP domain of PTPa crystal-
lizes as dimer, with the turn connecting helices aA and Sequence alignments of over 70 known SH2 domains
suggest that the interaction between the PTP and SH2aB of one molecule inserted into the catalytic cleft of
the other. As in SHP-2, this occludes the catalytic site domains in our structure is specific. The ªNxGDY/Fº
sequence motif of bD9-D9E-bE (which inserts deep intoand prevents rearrangement of the WPD loop.
Outside the catalytic cleft proper, a number of polar the PTP catalytic cleft) is unique to the N-SH2 domains
of SHP-1, SHP-2, and csw (Figure 3). These enzymesinteractions stabilize the inhibitory interaction. In the
N-SH2 domain, residues of helix aB and strands bA, must be regulated by a similar mechanism. Asn58 in this
motif is key to the SH2-PTP hydrogen bonding networkbD9, bE, and bF contribute to the extensive interaction
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Figure 2. The Structure of SHP-2 in Its Au-
toinhibited, Closed Configuration
Structures in (A) and (B) are in similar orienta-
tions. The N- and C-terminal SH2 domains are
yellow and green, respectively; the catalytic
PTP domain is blue, and interdomain linkers
(residues 104±111 and 217±220) are white in
both panels.
(A) Richardson diagram showing secondary
structure and organization of the domains.
Orange, the side chain of Cys459 (the cata-
lytic nucleophile); dashed lines, disordered
loops.
(B) All nonhydrogen atoms of SHP-2 are dis-
played. Although SH2 domain±bound pep-
tides are not present in our structure, resi-
dues of both domains known to contact
phosphopeptides (Lee et al., 1994; Eck et al.,
1996) are colored red. Note that peptide bind-
ing sites of both SH2 domains are exposed
on the molecule surface. A distinct surface
of the N-SH2 domain occupies the active site
of the PTP domain. Magenta, residues of the
PTP signature motif, HCSAGIGRS; these resi-
dues participate in catalysis and phosphate
binding.
(Figure 1B) and is not found at this position in any other al., 1996), both free and in complex with phosphopep-
tides, reveals these differences in conformation (FigureSH2 domain. The Gly in this motif may be required be-
cause the bond angles it adopts are not allowed for 6). In particular, the positions of the B helix and the
secondary b sheet (strands bD9, bE, and bF) changechiral amino acids (c 5 1348, φ 5 211.78). As discussed
above, Gly60 and Asp61 set up the hydrogen bond net- with respect to the A helix and the central sheet, which
remain fixed. The secondary b sheet and B helix interactwork to Cys459 (Figure 1B). The aromatic residue that
completes the motif (Tyr62 in SHP-2) is probably re- directlywith the PTP domain. The change inposition and
conformation of these elements upon phosphopeptidequired for binding the hydrophobic portion of the PTP
domain phosphotyrosine-binding site (Figure 4). binding disrupts the inhibitory interaction with the PTP
domain. We refer to the isolated, phosphopeptide-
bound conformation, which promotes activation of theThe N-SH2 Domain Is a Molecular Switch
phosphatase, as the ªAº state and the PTP associated,Given that separate surfaces of the N-SH2 domain inter-
inhibitory conformation as the ªIº state. Their superpo-act with phosphopeptide and thePTP domain, howdoes
sition (Figure 6A) shows that in the I state, the B-helixphosphoprotein binding to the SH2 domains activate
is displaced along its axis toward its C-terminal end bycatalysis? The structure of SHP-2 shows that its N-SH2
approximately 2 AÊ . The secondary b sheet is displaceddomain functions as an ªallostericº switch. Binding of a
as well, and this is accompanied by changes in its struc-phosphopeptide ligand at one site induces a transmitted
ture at both the PTP and phosphopeptide binding sur-conformational change that prevents PTP domain bind-
faces. The D9E turn is displaced by its insertion into theing at a second site, and vice versa. Comparison of the
PTP active site, and the EF loop folds in toward the BGN-SH2 domain in our structure with previously deter-
mined structures of the domain (Lee et al., 1994; Eck et loop, blocking the phosphopeptide binding groove of
Structure of the Tyrosine Phosphatase SHP-2
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Figure 3. Structure-Based Sequence Align-
ment of SHP-2 and Other Tyrosine Phospha-
tases
Sequences are of human SHP-2 and SHP-1,
csw, and the PTP domains of human PTPa
and PTP1B. Elements of SHP-2 secondary
structure are shown above the alignment.Re-
gions corresponding to the N-SH2, C-SH2,
and phosphatase domains are colored as in
Figure 2. Red squares, residues of the SHP-
2 N-SH2 and PTP domains that bind each
other; black squares, residues of the SHP-2
N-SH2 domain or PTP1B catalytic domain
that bind phosphopeptide; lavender squares,
catalytic residues of PTP1B. Residue num-
bers for SHP-2 and PTP1B are above and
below the alignment, respectively.
the SH2 domain (Figure 6B). The mainchain of the EF core residues. Because alanine at the bB4 position is
not compensated by observable ªsecond-site muta-loop (Tyr66-Gly67-Gly68) shifts by as much as 5.1 AÊ ,
relative to its position in the A state. The isolated, unli- tions,º this leaves a cavity in the N-SH2 domain. Similar
cavities render alternative proteins 2.5±5 kcal/mol lessganded N-SH2 domain is essentially in the A state (Lee
et al., 1994). Prior structures of the N-SH2 domain alone stable (Eriksson et al., 1992; Jackson et al., 1993a,
1993b; Baldwin et al., 1996). In the N-SH2 domain thisdid not reveal this switch, because the second confor-
mation, the inhibitory I state, is induced by interaction may ªloosen upº core packing to allow the apparent
sliding of the B helix. As a simple mechanical analogy,with the PTP domain.
We previously noted that the position of the B-helix the substitution could ªunlockº the B helix by removing
the larger sidechain, which would otherwise interdigitatein the liganded N-SH2 domain is divergent from that of
other SH2 domains, and we suggested that this might with the sidechains of the B helix, to fix its position
relative to the central sheet. Therefore, the alanine atresult from substitution of an alanine for the usual valine
at position bB4 (valine in the conserved ªFLVRESº sig- position bB4 may permit the formation of distinct I and
A states and facilitate interconversion by reducing thenature motif) (Eck et al., 1996). Alanine at this position
is unique to the N-terminal SH2 domains of the SH2 magnitude of the energy barrier between them.
phosphatases. Over 70 other SH2 domains, including
the C-terminal domains of these enzymes, contain Val,
Ile, or Leu at this position. The bulky bB4 sidechain A Model for SHP-2 Regulation
The conformational switch described above, togethercontributes to the hydrophobic core of other domains,
and it appears to fix the position of the B helix with with available biochemical data, suggests a model for
SHP-2 regulation. The N-SH2 domain has two ligands,respect to the central b sheet by interacting with other
Cell
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Figure 4. PTP Inhibition Compared to Substrate Recognition
The PTP domains of SHP-2 (left) and PTP1B (right) are shown in identical orientations. Turquoise, a helices; green, b strands; brown, intervening
random coils; lavender ball-and-stick models, side chains of key PTP residues; yellow, the SH2 domain in the SHP-2 structure (left) and the
phosphopeptide substrate in the PTP1B structure (right). Note that the SH2 domain occupies the entire phosphotyrosine-binding site.
which bind at nonoverlapping sites: an intermolecu- on the PTP (Figure 6A). Thus phosphopeptide binding
promotes intramolecular ªdissociationº of the N-SH2lar interaction with phosphopeptide, and an intramo-
lecular interaction with the PTP domain. These sites from the PTP, shifting the equilibrium to an open confor-
mation in which the steric block of the catalytic site isapparently interact with negative cooperativity. Under
basal conditions, in the absence of SH2 domain±binding relieved and SHP-2 is catalytically active.
Thermodynamic considerations require that the con-partners, the concentration of closed SHP-2 greatly ex-
ceeds that of the open form, as evidenced by very low verse must also be true: interaction of the N-SH2 with
the PTP must diminish its affinity for phosphopeptide.catalytic activity of the unliganded protein. In the
phosphopeptide-bound A state, the affinity of the N-SH2 We see the structural manifestations of the diminished
affinity of the I state for phosphopeptideÐmost obvi-domain for the PTP is diminished. This effect has been
demonstrated directly using isolated SHP-2 SH2 and ously the closed EF loop, which partially blocks the
peptide binding groove (Figure 6B). This observationPTP domains (Dechert et al., 1994). Further, our struc-
tural analysis shows that in the A state, the N-SH2 do- illuminates the role of the C-SH2 domain and two-site,
tandem SH2 domain±binding in enzymatic activationmain loses surface complementarity for its binding site
Figure 5. The N-SH2 Domain-PTP Domain
Interface Viewed as an ªOpen Bookº
The PTP (left) and N-SH2 (right) are both ro-
tated 908 but in opposite directions to expose
the buried surface between them. Contact
residues are numbered and color-coded to
reflect the percentage of surface buried (red,
50%±100%; orange, 25%±50%; yellow, 0%±
25%).
Structure of the Tyrosine Phosphatase SHP-2
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Figure 6. A Conformational Change in the
N-SH2 Domain Regulates SHP-2
(A) An a-carbon trace of the phosphopeptide-
bound A conformation of the N-SH2 domain
(red) (Eck et al., 1996) is superimposed on
the I state domain in the present structure
(yellow). The domains were superimposed
using the invariant portions of the structure
(residues 6±55) as determined by analysis of
difference distance matrix plots with the pro-
gram DDMP (Richards and Kundrot, 1988).
The molecular surface of the PTP and C-SH2
domains is shown in blue. Note that in the
peptide-bound A state, the N-SH2 backbone
(red) would collide with the surface of the PTP
domain.
(B) Molecular surfaces of the N-SH2 domain
from the SHP-2 structure (I state) and the iso-
lated SH2 domain bound to a phosphopep-
tide (A state) (Lee et al., 1994); the domains
are oriented similarly according to elements
of secondary structure. Residues of the EF
(66±68) and BG (89±92) loops are green and
red, respectively. A stick figure with carbon
colored white, the PDGFR 1009 peptide; blue,
nitrogen; red, oxygen; yellow, phosphorus.
Closure of the EF and BG loops in the I state
precludes high-affinityphosphopeptide bind-
ing. The change in shape of the N-SH2 do-
main that accompanies phosphopeptide bind-
ing destroys surface complementarity for the
PTP active site. Phosphopeptide binding thus
promotes dissociation of the N-SH2 and PTP
domains to generate the active A state of
SHP-2.
and biological function. By binding one site in a bisphos- distinct bisphosphotyrosyl sequencesderived from their
own biological partners, and tyrosines in these se-phoryl ligand, the C-SH2 domain provides binding en-
ergy and increases the local concentration of ligand so quences are separated by much shorter distances (9±11
residues between tyrosines in T cell receptor and FceRIthat the compromised N-SH2 domain can bind a second
site. Upon binding to the second site, the N-SH2 domain TAMs and related sites in thePDGF receptor) (Ottinger et
al., 1998). SHP-2 does not bind these alternative ligands,adopts the A state; this shifts the equilibrium to the
open, active form of the PTP. Engagement of the C-SH2 because phosphotyrosines within them are too close
together. However, SHP-2 is activated by homodimericdomain alone is unlikely to contribute to activation, be-
cause it makes only minimal contact with the other do- receptors such as the PDGF receptor that have single
recognition sites in each receptor monomer. Presum-mains. Although high concentrations of a monophos-
photyrosyl ligand can overcome the diminished affinity ably, the SH2 domains in SHP-2 bridge the dimer by
binding equivalent sites on each monomer.of the N-SH2 domain and activate SHP-2 in vitro, in the
context of cellular signaling, the one-to-one stoichiome- What role does the C terminus of SHP-2 play in enzy-
matic activation and biological function? SHP-2 may betry afforded by receptor activation is probably not suffi-
cient to recruit and activate SHP-2 via the N-SH2 alone. activated by limited proteolysis (Sugimoto et al., 1994).
Based on the mapping of a tryptic cleavage site to the CThe great distance between SH2 domain±binding
sitesÐover 50 AÊ between phosphotyrosine binding sites terminus of SHP-2, it was concluded that the C terminus
acts along with the SH2 domains to regulate catalysis.in this structureÐundoubtedly contributes to specificity.
Phosphotyrosines within SHP-1/SIRP proteins aresepa- However, engineered enzymes corresponding to trun-
cations around the tryptic site (e.g., 1±537; Sugimoto etrated by 23±25 residues, and relevant sites in IRS-1 are
even further apart (49 residues). SHP-2 binds corre- al., 1994) and shorter forms including the one used here
(1±527) all show activation profiles like the wild-typesponding bisphosphoryl peptides from these biological
partners with high affinity (KD z1 nM). In contrast, tan- protein. The C-terminal extension is phosphorylated in
activated cells (Feng et al., 1993; Vogel et al., 1993) anddem SH2 domains from alternative signaling proteins
(PI3-kinase p85,ZAP-70, Syk, and PLCg) bind with 1,000 may be a docking site for SH2 domain proteins (Welham
et al., 1994). However, the phosphorylation sites canto less than 10,000-fold lower affinity (Ottinger et al.,
1998). These other tandem SH2 domain proteins bind be eliminated without an apparent loss of function in
Cell
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PTP1B (Barford et al., 1994) (with side chains of nonconserved resi-transfected cells (Bennett et al., 1996) and injected frog
dues converted to L-Ala) as a search model. With considerationembryos (Tang et al., 1995; O'Reilly and Neel, 1998).
of crystal packing constraints and noncrystallographic symmetryGenetic studies in Drosophila suggest that the entire
operators, correct molecular replacement solutions for the N-termi-
C-terminal tail of csw is dispensable (Michael Simon, nal SH2 domains (Lee et al., 1994) were identified, but we were
personal communication). Our structure lacks the C-termi- unable to position the C-terminal SH2 domains. Electron density
maps phased with the partial replacement model were improvednal extension and therefore provides no direct informa-
with iterative, real-space noncrystallographic symmetry averaging,tion about its potential functions.
solvent flattening, and histogram matching using the program DM
(Cowtan, 1994) and associated programs in the CCP4 package (Col-Conclusions
laborative Computational Project 4, 1994). Averaging masks were
Although many signaling enzymes, including tyrosine positioned in the region of the C-SH2 domain and manually edited.
kinases, lipid kinases, and phospholipases, are con- The improved, averaged maps allowed construction of the C-SH2
domain and segments of the polypeptide chain linking the SH2 andstructed with structurally homologous modular do-
PTP domains. The model was refined to a crystallographic R valuemains, it is clear that distinct mechanisms must have
of 19.9% (Rfree 5 27.0%) with manual refitting, conjugate gradientevolved to control their activities. Comparison of the
minimization, and simulated annealing with programs MAIN (Turk,regulatory mechanisms employed in SHP-2 and in the
1996), O (Jones et al., 1989), and X-PLOR (Brunger, 1992). Tight
Src-family tyrosine kinases, the other class of SH2-regu- noncrystallographic symmetry restraints were maintained through-
lated enzyme for which structural detail is available out the refinement. There are no obvious differences between mole-
cules in the asymmetric unit; rms differences between selected(Sicheri et al., 1997; Williams et al., 1997; Xu et al., 1997),
atoms of each of the two N-SH2, C-SH2, and PTP domains in theshows how divergent structural mechanisms produce
asymmetric unit are 0.0352 AÊ , 0.0280 AÊ , and 0.0383 AÊ , respectively.related regulatory effects. In the Src kinases, the SH2
Water molecules were added with the aid of the program ARP (Lam-domain binds intramolecularly to the phosphorylated
zin and Wilson, 1993). The crystallized protein differs from the pub-
tail of the protein, and the SH3 domain binds to a linker lished sequence at three sites: Thr2Lys, Phe41Leu, and Phe513Ser.
segment. These interactions effectively clamp the two The cavity left by mutation of Phe513 binds a detergent molecule,
but the mutations do not otherwise alter the structure (the corre-lobes of the tyrosine kinase together in a manner that
sponding wild-type SHP-2 fragment crystallizes isomorphously, butdisrupts the active site and simultaneously blocks the
suitable crystals for structure determination were not obtained). Theligand binding surfaces of the SH3 and SH2 domains.
final model contains 7928 protein atoms (2 SHP-2 molecules), 777The single-domain architecture of the phosphatase do-
solvent molecules, and 2 detergent molecules (CTAB). All residues
main requires a more direct form of inhibition: a steric in both proteins of the asymmetric unit are identified except residues
block of the catalytic cleft by the SH2 domain. Despite 156±160, 236±245, 295±301, and 313±323. These three disordered
loops in the PTP domain and one in the C-terminal SH2 domain aredramatically different mechanisms and distinct architec-
not involved in catalytic or known binding functions of the protein.tures, the SH2 domain phosphatases and Src-family
Figures 1B, 4, and 5 were prepared using the program RIBBONSkinases are both constructed and ªtunedº such that
(Carson, 1991); Figure 1A was made with O (Jones, 1989); Figurehigh-affinity, intermolecular binding is required to break
2B was made with MAIN (Turk, 1996); Figure 2A was made with
the inhibitory intramolecular effects of the targeting do- MOLSCRIPT (Kraulis, 1991); and Figures 6A and 6B were made
mains. In both cases, intracellular targeting and enzyme with GRASP (Nicholls et al., 1991). Coordinates have been depos-
ited at the PDB in Brookhaven under code 2SHP and can be ob-activation are intimately coupled. This is likely a common
tained by e-mail from eck@red.dfci.harvard.edu or shoelson@joslab.theme in signaling proteins.
harvard.edu.
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